Brilinta keeps blood platelets from clotting (coagulating) to prevent unwanted blood clots that can occur with certain heart or blood vessel conditions. The medication is used to lower the risk of stroke or serious heart problems after a patient has had a heart attack or severe chest pain (angina). Brilinta is made by AstraZeneca and was approved by the FDA in July 2011.
According to the FDA Medication Guide, Brilinta “can cause bleeding events that can be serious and sometimes lead to death.” These types of bleeding events may result in the need for a blood transfusion or surgery.
If you are a Brilinta user, you may be at an increased risk for:
- Bruising and bleeding more easily
- Frequent nose bleeds
- Bleeding events that take longer to stop
To date, Brilinta has not been recalled in the U.S. or any other country. However, the investigation into the drug is still in its early stages, and patients who have been injured may be able to file a product liability lawsuit against the manufacturer. If our lawyers determine that you have a valid claim, you may be awarded a settlement to help with medical expenses, lost wages, pain and suffering, and more. Contact us today to learn more about your legal rights.
If you need a lawyer with significant experience handling Brilinta cases, please call Kirtland & Packard, LLP today at 310-536-1000 for a free consultation. We're located in California.